2015-2025 Global Cancer Targeted Therapy Market Research by Type, End-Use and Region

2015-2025 Global Cancer Targeted Therapy Market Research by Type, End-Use and Region

Table of Contents

CHAPTER 1 MARKET OVERVIEW
1.1 Market Definition and Segment
1.1.1 Product Definition
1.1.2 Product Type
1.1.3 End-Use
1.1.4 Marketing Channel
1.2 Major Regions
1.2.1 Europe Market Size and Growth
Figure Europe Cancer Targeted Therapy Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Cancer Targeted Therapy Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.2 America Market Size and Growth
Figure America Cancer Targeted Therapy Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Cancer Targeted Therapy Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.3 Asia Market Size and Growth
Figure Asia Cancer Targeted Therapy Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaCancer Targeted Therapy Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.4 Oceania Market Size and Growth
Figure Oceania Cancer Targeted Therapy Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Cancer Targeted Therapy Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.5 Africa Market Size and Growth
Figure Africa Cancer Targeted Therapy Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Cancer Targeted Therapy Market Forecast and Growth Rate, 2020E-2025F (Million USD)
CHAPTER 2 GLOBAL MARKET SEGMENTATION
2.1 Global Production Overview
Table Global Cancer Targeted Therapy Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
2.2 Global Consumption Overview
Table Global Cancer Targeted Therapy Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
2.3 Global Production by Type
Table Global Cancer Targeted Therapy Revenue by Type, 2015-2020 (Million USD)
Figure Global Cancer Targeted Therapy Revenue Share by Type in 2020 (Million USD)
Table Global Cancer Targeted Therapy Production Volume by Type, 2015-2020 (Volume)
Figure Global Cancer Targeted Therapy Production Volume Share by Type in 2020 (Volume)
2.4 Global Consumption by End-Use
Table Global Cancer Targeted Therapy Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Global Cancer Targeted Therapy Consumption Value Share by End-Use in 2020 (Million USD)
Table Global Cancer Targeted Therapy Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Global Cancer Targeted Therapy Consumption Volume Share by End-Use in 2020 (Volume)
2.5 Global Consumption by Region
Table Global Cancer Targeted Therapy Consumption Value by Region, 2015-2020 (Million USD)
Table Global Cancer Targeted Therapy Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 3 Europe MARKET SEGMENTATION
3.1 Europe Production Overview
Table Europe Cancer Targeted Therapy Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
3.2 Europe Consumption Overview
Table Europe Cancer Targeted Therapy Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
3.3 Europe Production by Type
Table Europe Cancer Targeted Therapy Revenue by Type, 2015-2020 (Million USD)
Figure Europe Cancer Targeted Therapy Revenue Share by Type in 2020 (Million USD)
Table Europe Cancer Targeted Therapy Production Volume by Type, 2015-2020 (Volume)
Figure Europe Cancer Targeted Therapy Production Volume Share by Type in 2020 (Volume)
3.4 Europe Consumption by End-Use
Table Europe Cancer Targeted Therapy Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Europe Cancer Targeted Therapy Consumption Value Share by End-Use in 2020 (Million USD)
Table Europe Cancer Targeted Therapy Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Europe Cancer Targeted Therapy Consumption Volume Share by End-Use in 2020 (Volume)
3.5 Europe Consumption by Region
Table Europe Cancer Targeted Therapy Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Cancer Targeted Therapy Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 4 AMERICA MARKET SEGMENTATION
4.1 America Production Overview
Table America Cancer Targeted Therapy Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
4.2 America Consumption Overview
Table America Cancer Targeted Therapy Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
4.3 America Production by Type
Table America Cancer Targeted Therapy Revenue by Type, 2015-2020 (Million USD)
Figure America Cancer Targeted Therapy Revenue Share by Type in 2020 (Million USD)
Table America Cancer Targeted Therapy Production Volume by Type, 2015-2020 (Volume)
Figure America Cancer Targeted Therapy Production Volume Share by Type in 2020 (Volume)
4.4 America Consumption by End-Use
Table America Cancer Targeted Therapy Consumption Value by End-Use, 2015-2020 (Million USD)
Figure America Cancer Targeted Therapy Consumption Value Share by End-Use in 2020 (Million USD)
Table America Cancer Targeted Therapy Consumption Volume by End-Use, 2015-2020 (Volume)
Figure America Cancer Targeted Therapy Consumption Volume Share by End-Use in 2020 (Volume)
4.5 America Consumption by Region
Table America Cancer Targeted Therapy Consumption Value by Region, 2015-2020 (Million USD)
Table America Cancer Targeted Therapy Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 5 ASIA MARKET SEGMENTATION
5.1 Asia Production Overview
Table Asia Cancer Targeted Therapy Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
5.2 Asia Consumption Overview
Table Asia Cancer Targeted Therapy Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
5.3 Asia Production by Type
Table Asia Cancer Targeted Therapy Revenue by Type, 2015-2020 (Million USD)
Figure Asia Cancer Targeted Therapy Revenue Share by Type in 2020 (Million USD)
Table Asia Cancer Targeted Therapy Production Volume by Type, 2015-2020 (Volume)
Figure Asia Cancer Targeted Therapy Production Volume Share by Type in 2020 (Volume)
5.4 Asia Consumption by End-Use
Table Asia Cancer Targeted Therapy Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Asia Cancer Targeted Therapy Consumption Value Share by End-Use in 2020 (Million USD)
Table Asia Cancer Targeted Therapy Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Asia Cancer Targeted Therapy Consumption Volume Share by End-Use in 2020 (Volume)
5.5 Asia Consumption by Region
Table Asia Cancer Targeted Therapy Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Cancer Targeted Therapy Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 6 OCEANIA MARKET SEGMENTATION
6.1 Oceania Production Overview
Table Oceania Cancer Targeted Therapy Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
6.2 Oceania Consumption Overview
Table Oceania Cancer Targeted Therapy Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
6.3 Oceania Production by Type
Table Oceania Cancer Targeted Therapy Revenue by Type, 2015-2020 (Million USD)
Figure Oceania Cancer Targeted Therapy Revenue Share by Type in 2020 (Million USD)
Table Oceania Cancer Targeted Therapy Production Volume by Type, 2015-2020 (Volume)
Figure Oceania Cancer Targeted Therapy Production Volume Share by Type in 2020 (Volume)
6.4 Oceania Consumption by End-Use
Table Oceania Cancer Targeted Therapy Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Oceania Cancer Targeted Therapy Consumption Value Share by End-Use in 2020 (Million USD)
Table Oceania Cancer Targeted Therapy Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Oceania Cancer Targeted Therapy Consumption Volume Share by End-Use in 2020 (Volume)
6.5 Oceania Consumption by Region
Table Oceania Cancer Targeted Therapy Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Cancer Targeted Therapy Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 7 AFRICA MARKET SEGMENTATION
7.1 Africa Production Overview
Table Africa Cancer Targeted Therapy Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
7.2 Africa Consumption Overview
Table Africa Cancer Targeted Therapy Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
7.3 Africa Production by Type
Table Africa Cancer Targeted Therapy Revenue by Type, 2015-2020 (Million USD)
Figure Africa Cancer Targeted Therapy Revenue Share by Type in 2020 (Million USD)
Table Africa Cancer Targeted Therapy Production Volume by Type, 2015-2020 (Volume)
Figure Africa Cancer Targeted Therapy Production Volume Share by Type in 2020 (Volume)
7.4 Africa Consumption by End-Use
Table Africa Cancer Targeted Therapy Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Africa Cancer Targeted Therapy Consumption Value Share by End-Use in 2020 (Million USD)
Table Africa Cancer Targeted Therapy Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Africa Cancer Targeted Therapy Consumption Volume Share by End-Use in 2020 (Volume)
7.5 Africa Consumption by Region
Table Africa Cancer Targeted Therapy Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Cancer Targeted Therapy Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 8 GLOBAL MARKET FORECAST
8.1 Global Cancer Targeted Therapy Production Forecast
Figure Global Cancer Targeted Therapy Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Cancer Targeted Therapy Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
8.2 Global Cancer Targeted Therapy Forecast by Type
Table Global Cancer Targeted Therapy Revenue by Type, 2020E-2025F (Million USD)
Figure Global Cancer Targeted Therapy Revenue Share by Type in 2025 (Million USD)
Table Global Cancer Targeted Therapy Production Volume by Type, 2020E-2025F (Volume)
Figure Global Cancer Targeted Therapy Production Volume Share by Type in 2025 (Volume)
8.3 Global Cancer Targeted Therapy Forecast by End-Use (2020E-2025F)
Table Global Cancer Targeted Therapy Consumption Value by End-Use, 2020E-2025F (Million USD)
Figure Global Cancer Targeted Therapy Consumption Value Share by End-Use in 2025 (Million USD)
Table Global Cancer Targeted Therapy Consumption Volume by End-Use, 2020E-2025F (Volume)
8.4 Global Cancer Targeted Therapy Forecast by Region (2020E-2025F)
Table Global Cancer Targeted Therapy Consumption Value by Region, 2020E-2025F (Million USD)
Figure Global Cancer Targeted Therapy Consumption Value Share by Region in 2025 (Million USD)
Table Global Cancer Targeted Therapy Consumption Volume by Region, 2020E-2025F (Volume)
Figure Global Cancer Targeted Therapy Consumption Volume Share by Region in 2025 (Volume)
CHAPTER 9 GLOBAL MAJOR COMPANIES LIST
9.1 Advaxis
9.1.1 Advaxis Profile
Table Advaxis Overview List
9.1.2 Advaxis Products & Services
9.1.3 Advaxis Company Dynamics & News
9.1.4 Advaxis Business Operation Conditions
Table Business Operation of Advaxis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.2 Bind Therapeutics
9.2.1 Bind Therapeutics Profile
Table Bind Therapeutics Overview List
9.2.2 Bind Therapeutics Products & Services
9.2.3 Bind Therapeutics Company Dynamics & News
9.2.4 Bind Therapeutics Business Operation Conditions
Table Business Operation of Bind Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.3 Boehringer Ingelheim
9.3.1 Boehringer Ingelheim Profile
Table Boehringer Ingelheim Overview List
9.3.2 Boehringer Ingelheim Products & Services
9.3.3 Boehringer Ingelheim Company Dynamics & News
9.3.4 Boehringer Ingelheim Business Operation Conditions
Table Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.4 Bristol Mayer Squibb
9.4.1 Bristol Mayer Squibb Profile
Table Bristol Mayer Squibb Overview List
9.4.2 Bristol Mayer Squibb Products & Services
9.4.3 Bristol Mayer Squibb Company Dynamics & News
9.4.4 Bristol Mayer Squibb Business Operation Conditions
Table Business Operation of Bristol Mayer Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.5 Celldex Therapeutics
9.5.1 Celldex Therapeutics Profile
Table Celldex Therapeutics Overview List
9.5.2 Celldex Therapeutics Products & Services
9.5.3 Celldex Therapeutics Company Dynamics & News
9.5.4 Celldex Therapeutics Business Operation Conditions
Table Business Operation of Celldex Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.6 Dendreon Corporation
9.6.1 Dendreon Corporation Profile
Table Dendreon Corporation Overview List
9.6.2 Dendreon Corporation Products & Services
9.6.3 Dendreon Corporation Company Dynamics & News
9.6.4 Dendreon Corporation Business Operation Conditions
Table Business Operation of Dendreon Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.7 Eli Lily
9.7.1 Eli Lily Profile
Table Eli Lily Overview List
9.7.2 Eli Lily Products & Services
9.7.3 Eli Lily Company Dynamics & News
9.7.4 Eli Lily Business Operation Conditions
Table Business Operation of Eli Lily (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.8 GalaxoSmithKline
9.8.1 GalaxoSmithKline Profile
Table GalaxoSmithKline Overview List
9.8.2 GalaxoSmithKline Products & Services
9.8.3 GalaxoSmithKline Company Dynamics & News
9.8.4 GalaxoSmithKline Business Operation Conditions
Table Business Operation of GalaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.9 Galena Biopharma
9.9.1 Galena Biopharma Profile
Table Galena Biopharma Overview List
9.9.2 Galena Biopharma Products & Services
9.9.3 Galena Biopharma Company Dynamics & News
9.9.4 Galena Biopharma Business Operation Conditions
Table Business Operation of Galena Biopharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.10 Genetech
9.10.1 Genetech Profile
Table Genetech Overview List
9.10.2 Genetech Products & Services
9.10.3 Genetech Company Dynamics & News
9.10.4 Genetech Business Operation Conditions
Table Business Operation of Genetech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.11 ImmunoCellular Therapeutics
9.11.1 ImmunoCellular Therapeutics Profile
Table ImmunoCellular Therapeutics Overview List
9.11.2 ImmunoCellular Therapeutics Products & Services
9.11.3 ImmunoCellular Therapeutics Company Dynamics & News
9.11.4 ImmunoCellular Therapeutics Business Operation Conditions
Table Business Operation of ImmunoCellular Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.12 ImmunoGen
9.12.1 ImmunoGen Profile
Table ImmunoGen Overview List
9.12.2 ImmunoGen Products & Services
9.12.3 ImmunoGen Company Dynamics & News
9.12.4 ImmunoGen Business Operation Conditions
Table Business Operation of ImmunoGen (Sales Revenue, Cost, Gross Margin)
9.13 Inovio Pharmaceuticals
9.13.1 Inovio Pharmaceuticals Profile
Table Inovio Pharmaceuticals Overview List
9.13.2 Inovio Pharmaceuticals Products & Services
9.13.3 Inovio Pharmaceuticals Company Dynamics & News
9.13.4 Inovio Pharmaceuticals Business Operation Conditions
Table Business Operation of Inovio Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.14 Johnson & Johnson
9.14.1 Johnson & Johnson Profile
Table Johnson & Johnson Overview List
9.14.2 Johnson & Johnson Products & Services
9.14.3 Johnson & Johnson Company Dynamics & News
9.14.4 Johnson & Johnson Business Operation Conditions
Table Business Operation of Johnson & Johnson (Sales Revenue, Cost, Gross Margin)
9.15 NeoStem Oncology
9.15.1 NeoStem Oncology Profile
Table NeoStem Oncology Overview List
9.15.2 NeoStem Oncology Products & Services
9.15.3 NeoStem Oncology Company Dynamics & News
9.15.4 NeoStem Oncology Business Operation Conditions
Table Business Operation of NeoStem Oncology (Sales Revenue, Cost, Gross Margin)
9.16 NewLink Genetics
9.16.1 NewLink Genetics Profile
Table NewLink Genetics Overview List
9.16.2 NewLink Genetics Products & Services
9.16.3 NewLink Genetics Company Dynamics & News
9.16.4 NewLink Genetics Business Operation Conditions
Table Business Operation of NewLink Genetics (Sales Revenue, Cost, Gross Margin)
9.17 Northwest Biotherapeutics
9.17.1 Northwest Biotherapeutics Profile
Table Northwest Biotherapeutics Overview List
9.17.2 Northwest Biotherapeutics Products & Services
9.17.3 Northwest Biotherapeutics Company Dynamics & News
9.17.4 Northwest Biotherapeutics Business Operation Conditions
Table Business Operation of Northwest Biotherapeutics (Sales Revenue, Cost, Gross Margin)
9.18 Merck
9.18.1 Merck Profile
Table Merck Overview List
9.18.2 Merck Products & Services
9.18.3 Merck Company Dynamics & News
9.18.4 Merck Business Operation Conditions
Table Business Operation of Merck (Sales Revenue, Cost, Gross Margin)
9.19 Novartis
9.19.1 Novartis Profile
Table Novartis Overview List
9.19.2 Novartis Products & Services
9.19.3 Novartis Company Dynamics & News
9.19.4 Novartis Business Operation Conditions
Table Business Operation of Novartis (Sales Revenue, Cost, Gross Margin)
9.20 Peregrine Pharmaceuticals
9.20.1 Peregrine Pharmaceuticals Profile
Table Peregrine Pharmaceuticals Overview List
9.20.2 Peregrine Pharmaceuticals Products & Services
9.20.3 Peregrine Pharmaceuticals Company Dynamics & News
9.20.4 Peregrine Pharmaceuticals Business Operation Conditions
Table Business Operation of Peregrine Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
9.21 Pfizer
9.21.1 Pfizer Profile
Table Pfizer Overview List
9.21.2 Pfizer Products & Services
9.21.3 Pfizer Company Dynamics & News
9.21.4 Pfizer Business Operation Conditions
Table Business Operation of Pfizer (Sales Revenue, Cost, Gross Margin)
9.22 Roche
9.22.1 Roche Profile
Table Roche Overview List
9.22.2 Roche Products & Services
9.22.4 Roche Business Operation Conditions
Table Business Operation of Roche (Sales Revenue, Cost, Gross Margin)
9.23 Sanofi
9.23.1 Sanofi Profile
Table Sanofi Overview List
9.23.2 Sanofi Products & Services
9.23.3 Sanofi Company Dynamics & News
9.23.4 Sanofi Business Operation Conditions
Table Business Operation of Sanofi (Sales Revenue, Cost, Gross Margin)
9.24 Seattle Genetics
9.24.1 Seattle Genetics Profile
Table Seattle Genetics Overview List
9.24.2 Seattle Genetics Products & Services
9.24.3 Seattle Genetics Company Dynamics & News
9.24.4 Seattle Genetics Business Operation Conditions
Table Business Operation of Seattle Genetics (Sales Revenue, Cost, Gross Margin)
9.25 Teva
9.25.1 Teva Profile
Table Teva Overview List
9.25.2 Teva Products & Services
9.25.3 Teva Company Dynamics & News
9.25.4 Teva Business Operation Conditions
Table Business Operation of Teva (Sales Revenue, Cost, Gross Margin)
PART 10 MARKET COMPETITION
10.1 Key Company Market Share
Table Global Cancer Targeted Therapy Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Cancer Targeted Therapy Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Cancer Targeted Therapy Sales Volume by Companies, 2015-2020E (Volume)
Table Global Cancer Targeted Therapy Sales Volume Share by Companies, 2015-2020E (Volume)
10.2 Regional Market Concentration
Figure Europe Cancer Targeted Therapy Market Concentration Ratio in 2020E
Figure America Cancer Targeted Therapy Market Concentration Ratio in 2020E
Figure Asia Cancer Targeted Therapy Market Concentration Ratio in 2020E
Figure Oceania Cancer Targeted Therapy Market Concentration Ratio in 2020E
Figure Africa Cancer Targeted Therapy Market Concentration Ratio in 2020E
PART 11 CORONAVIRUS IMPACT ON Cancer Targeted Therapy INDUSTRY
11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment
PART 12 Cancer Targeted Therapy INDUSTRY SUMMARY & CONCLUSION

List of Tables

Table Global Cancer Targeted Therapy Revenue by Type, 2015-2020 (Million USD)
Table Global Cancer Targeted Therapy Production Volume by Type, 2015-2020 (Volume)
Table Global Cancer Targeted Therapy Consumption Value by End-Use, 2015-2020 (Million USD)
Table Global Cancer Targeted Therapy Consumption Volume by End-Use, 2015-2020 (Volume)
Table Global Cancer Targeted Therapy Consumption Value by Region, 2015-2020 (Million USD)
Table Global Cancer Targeted Therapy Consumption Volume by Region, 2015-2020 (Volume)
Table Europe Cancer Targeted Therapy Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Europe Cancer Targeted Therapy Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Europe Cancer Targeted Therapy Revenue by Type, 2015-2020 (Million USD)
Table Europe Cancer Targeted Therapy Production Volume by Type, 2015-2020 (Volume)
Table Europe Cancer Targeted Therapy Consumption Value by End-Use, 2015-2020 (Million USD)
Table Europe Cancer Targeted Therapy Consumption Volume by End-Use, 2015-2020 (Volume)
Table Europe Cancer Targeted Therapy Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Cancer Targeted Therapy Consumption Volume by Region, 2015-2020 (Volume)
Table America Cancer Targeted Therapy Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table America Cancer Targeted Therapy Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table America Cancer Targeted Therapy Revenue by Type, 2015-2020 (Million USD)
Table America Cancer Targeted Therapy Production Volume by Type, 2015-2020 (Volume)
Table America Cancer Targeted Therapy Consumption Value by End-Use, 2015-2020 (Million USD)
Table America Cancer Targeted Therapy Consumption Volume by End-Use, 2015-2020 (Volume)
Table America Cancer Targeted Therapy Consumption Value by Region, 2015-2020 (Million USD)
Table America Cancer Targeted Therapy Consumption Volume by Region, 2015-2020 (Volume)
Table Asia Cancer Targeted Therapy Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Asia Cancer Targeted Therapy Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Asia Cancer Targeted Therapy Revenue by Type, 2015-2020 (Million USD)
Table Asia Cancer Targeted Therapy Production Volume by Type, 2015-2020 (Volume)
Table Asia Cancer Targeted Therapy Consumption Value by End-Use, 2015-2020 (Million USD)
Table Asia Cancer Targeted Therapy Consumption Volume by End-Use, 2015-2020 (Volume)
Table Asia Cancer Targeted Therapy Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Cancer Targeted Therapy Consumption Volume by Region, 2015-2020 (Volume)
Table Oceania Cancer Targeted Therapy Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Oceania Cancer Targeted Therapy Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Oceania Cancer Targeted Therapy Revenue by Type, 2015-2020 (Million USD)
Table Oceania Cancer Targeted Therapy Production Volume by Type, 2015-2020 (Volume)
Table Oceania Cancer Targeted Therapy Consumption Value by End-Use, 2015-2020 (Million USD)
Table Oceania Cancer Targeted Therapy Consumption Volume by End-Use, 2015-2020 (Volume)
Table Oceania Cancer Targeted Therapy Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Cancer Targeted Therapy Consumption Volume by Region, 2015-2020 (Volume)
Table Africa Cancer Targeted Therapy Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Africa Cancer Targeted Therapy Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Africa Cancer Targeted Therapy Revenue by Type, 2015-2020 (Million USD)
Table Africa Cancer Targeted Therapy Production Volume by Type, 2015-2020 (Volume)
Table Africa Cancer Targeted Therapy Consumption Value by End-Use, 2015-2020 (Million USD)
Table Africa Cancer Targeted Therapy Consumption Volume by End-Use, 2015-2020 (Volume)
Table Africa Cancer Targeted Therapy Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Cancer Targeted Therapy Consumption Volume by Region, 2015-2020 (Volume)
Table Global Cancer Targeted Therapy Revenue by Type, 2020E-2025F (Million USD)
Table Global Cancer Targeted Therapy Production Volume by Type, 2020E-2025F (Volume)
Table Global Cancer Targeted Therapy Consumption Value by End-Use, 2020E-2025F (Million USD)
Table Global Cancer Targeted Therapy Consumption Volume by End-Use, 2020E-2025F (Volume)
Table Global Cancer Targeted Therapy Consumption Value by Region, 2020E-2025F (Million USD)
Table Global Cancer Targeted Therapy Consumption Volume by Region, 2020E-2025F (Volume)
Table Advaxis Overview List
Table Business Operation of Advaxis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bind Therapeutics Overview List
Table Business Operation of Bind Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Boehringer Ingelheim Overview List
Table Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bristol Mayer Squibb Overview List
Table Business Operation of Bristol Mayer Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Celldex Therapeutics Overview List
Table Business Operation of Celldex Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Dendreon Corporation Overview List
Table Business Operation of Dendreon Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eli Lily Overview List
Table Business Operation of Eli Lily (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GalaxoSmithKline Overview List
Table Business Operation of GalaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Galena Biopharma Overview List
Table Business Operation of Galena Biopharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Genetech Overview List
Table Business Operation of Genetech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table ImmunoCellular Therapeutics Overview List
Table Business Operation of ImmunoCellular Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table ImmunoGen Overview List
Table Business Operation of ImmunoGen (Sales Revenue, Cost, Gross Margin)
Table Inovio Pharmaceuticals Overview List
Table Business Operation of Inovio Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Johnson & Johnson Overview List
Table Business Operation of Johnson & Johnson (Sales Revenue, Cost, Gross Margin)
Table NeoStem Oncology Overview List
Table Business Operation of NeoStem Oncology (Sales Revenue, Cost, Gross Margin)
Table NewLink Genetics Overview List
Table Business Operation of NewLink Genetics (Sales Revenue, Cost, Gross Margin)
Table Northwest Biotherapeutics Overview List
Table Business Operation of Northwest Biotherapeutics (Sales Revenue, Cost, Gross Margin)
Table Merck Overview List
Table Business Operation of Merck (Sales Revenue, Cost, Gross Margin)
Table Novartis Overview List
Table Business Operation of Novartis (Sales Revenue, Cost, Gross Margin)
Table Peregrine Pharmaceuticals Overview List
Table Business Operation of Peregrine Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
Table Pfizer Overv

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global 5-Fluorouracil Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76

The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......

Global Carboplatin Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......

Global Neutropenia Drugs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96

The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......

Global Small Molecule Cancer Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......

Global Capecitabine Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80

Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......

Global Oxaliplatin Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104

Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......

Global Cancer Treatment Drugs Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158

According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......

Global Capecitabine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93

According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......

Global Methotrexate Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs